Compugen Ltd Stock Prediction
AI-powered sentiment analysis and prediction trends for CGEN, updated each market day.
CGEN AI Sentiment
AI predicts Compugen Ltd stock is likely to decrease over the next 10 market days.
Prediction date: Sept. 22, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Compugen Ltd
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
Exchange
Market Cap
$233,030,697
Cap Tier
Employees
75
Listed Since
Aug. 11, 2000
Website
CGEN Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
CGEN Volatility
Compugen Ltd has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
